ROYAL BANK OF CANADA - ATOSSA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$0194
+12.1%
0.00%
Q2 2023$0173
+765.0%
0.00%
Q1 2023$020
+100.0%
0.00%
Q2 2022$0
-100.0%
10
-99.9%
0.00%
Q1 2022$9,000
-76.3%
7,189
-69.9%
0.00%
Q4 2021$38,000
-46.5%
23,909
+10.6%
0.00%
Q3 2021$71,000
-31.7%
21,619
+31.7%
0.00%
Q2 2021$104,000
+2500.0%
16,410
+720.5%
0.00%
Q1 2021$4,0002,0000.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
QCM Cayman, Ltd. 22,301$36,0000.22%
XTX Topco Ltd 17,275$28,0000.02%
TWO SIGMA INVESTMENTS, LP 2,371,193$3,794,0000.01%
TWO SIGMA ADVISERS, LP 1,597,930$2,557,0000.01%
D. E. Shaw & Co., Inc. 4,147,809$6,637,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 129,916$208,0000.01%
Graham Capital Management, L.P. 73,105$116,0000.01%
Caption Management, LLC 300,000$480,0000.01%
Engineers Gate Manager LP 60,809$97,0000.00%
Castleview Partners, LLC 800$500,0000.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders